(Q44605688)

4 December 2017

title

Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells (English)

1 reference

4 December 2017

0 references

6

Lorne A Babiuk

1 reference

4 December 2017

7

George K Mutwiri

1 reference

4 December 2017

4

Arshud Dar

1 reference

4 December 2017

1

Jayaum S Booth

1 reference

4 December 2017

2

Anil K Nichani

1 reference

4 December 2017

Ponn Benjamin

3

1 reference

4 December 2017

Arthur M Krieg

series ordinal

5

1 reference

4 December 2017

publication date

26 September 2006

1 reference

Veterinary Immunology and Immunopathology

4 December 2017

published in

1 reference

4 December 2017

volume

115

1 reference

4 December 2017

issue

1-2

1 reference

4 December 2017

page(s)

24-34

1 reference

Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacyto

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Enrichment for a CD26hi SIRP- subset in lymph dendritic cells from the upper aero-digestive tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Fetal immunization by a DNA vaccine delivered into the oral cavity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Protection of chickens against Escherichia coli infections by DNA containing CpG motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG oligonucleotides induce strong humoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

A road less travelled: large animal models in immunological research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Development of detection methods for ruminant interleukin (IL)-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

A slow release formulation for recombinant bovine interferon alpha I-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG oligodeoxynucleotides and plasmid DNA stimulate Atlantic salmon (Salmo salar L.) leucocytes to produce supernatants with antiviral activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG DNA: recognition by and activation of monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Direct immunologic activities of CpG DNA and implications for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG motifs in bacterial DNA and their immune effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG motifs in bacterial DNA trigger direct B-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Superior activity of the type C class of ISS in vitro and in vivo across multiple species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

HIV-Specific CD4(+) and CD8(+) immune responses are generated with a gp120-depleted, whole-killed HIV-1 immunogen with CpG immunostimulatory sequences of DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Immunology. After the toll rush

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Type I interferon-mediated stimulation of T cells by CpG DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Interleukin-12 and the regulation of innate resistance and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.09.008

10.1016/J.VETIMM.2006.09.008

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference